Yahoo Web Search

Search results

  1. May 22, 2024 · AVTX Avalo Therapeutics, Inc. Stock Price & Overview. Follow. 3.52K followers. $10.79 -0.13 ( -1.19%) 3:59 PM 05/22/24. NASDAQ | $USD | Post-Market: $9.60 -1.19 (-11.03%) 7:59 PM. Summary....

  2. May 23, 2024 · AVTX is a biotech company developing anti-inflammatory drugs. See its stock performance, valuation, financials, and industry comparables on Morningstar.com.

  3. 5 days ago · Stock analysis for Avalo Therapeutics Inc (AVTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

    • 19
  4. 4 days ago · Free AVTX Stock Alerts. $13.10. +1.95 (+17.49%) (As of 05/24/2024 ET) Compare. Share. Today's Range. $10.98. . $13.23. 50-Day Range. $4.35. . $21.75. 52-Week Range. $3.95. . $1,130.40. Volume. 44,830 shs. Average Volume. 54,215 shs. Market Capitalization. $13.49 million. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. N/A. Stock Analysis.

    • 540 Gaither Rd Ste 400, Rockville, Maryland 20850-6713
    • ir@cerecor.com
    • (410) 522-8707
    • 19
  5. People also ask

  6. 6 days ago · Avalo Therapeutics is a biotech company developing treatments for inflammatory and autoimmune diseases. See its latest stock price, earnings, news, financials, statistics, forecast and chart on Stock Analysis.

    • AVTX Stock1
    • AVTX Stock2
    • AVTX Stock3
    • AVTX Stock4
  7. May 21, 2024 · Avalo Therapeutics, Inc. (AVTX.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Avalo Therapeutics, Inc. | Nasdaq: AVTX | Nasdaq.

  8. May 20, 2024 · 1Y. -98.5% Updated. 20 May, 2024. Data. Company Financials +. 1 Analyst. AVTX Stock Overview. A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. About the company. Rewards. Risk Analysis. Does not have a meaningful market cap ($10M)

  1. People also search for